TIPS Block vs. IV Analgesia for Postoperative Pain After Knee Arthroscopy

Launched by AIN SHAMS UNIVERSITY · Jun 29, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at two different ways to manage pain after knee arthroscopy, which is a type of knee surgery. The study compares a special nerve block called the triple injection peri-sartorius (TIPS) block, where medicine is injected near nerves to numb the area, with the usual method of giving pain medicine through an IV (a drip in the vein). The goal is to see which method provides better pain relief and helps patients start walking sooner after surgery.

Adults between 18 and 40 years old who are having knee arthroscopy and are generally healthy (based on a standard health assessment) may be able to join the study. People who have certain health problems like serious liver, kidney, or heart disease, allergies to the study medicines, or issues that prevent regional anesthesia (like infections or bleeding problems) will not be eligible. Participants can expect to receive either the nerve block or IV pain medicine after their surgery and will be monitored to see how well their pain is controlled and how quickly they can move around. This study is not yet recruiting, so if you or a family member are considering this, it’s good to check back later for updates.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • .Age 18-40 years undergoing knee arthroscopy. .Sex: Both sexes.
• • .American Society of Anaesthesiologists (ASA) Physical Status Class I and II
• Exclusion Criteria:
• • .Declining to give written informed consent. .History of allergy to the medications used in the study. .Contraindications to regional anesthesia (including patient refusal, coagulopathy and local infection).
• • Psychiatric disorder. .American Society of Anesthesiologists (ASA) Physical Status Class III and IV.
• • Patients with body mass index (BMI) \>35 kg/m2 .Neurological deficits or mobility-related disorders of the non-operated limb .
• • Moderate to severe hepatic , renal diseases and cardiac disease.